TSE:MSL - Merus Labs International Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseC$1.64Today's RangeC$1.64 - C$1.6552-Week RangeC$0.95 - C$1.76Volume21,975 shsAverage Volume476,228 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency. Receive MSL News and Ratings via Email Sign-up to receive the latest news and ratings for MSL and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolTSE:MSL Previous Symbol CUSIPN/A CIKN/A Webwww.meruslabs.com Phone+1-905-7260995Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Merus Labs International (TSE:MSL) Frequently Asked Questions What is Merus Labs International's stock symbol? Merus Labs International trades on the Toronto Stock Exchange (TSX) under the ticker symbol "MSL." Has Merus Labs International been receiving favorable news coverage? Headlines about MSL stock have been trending extremely negative on Tuesday, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Merus Labs International earned a coverage optimism score of -4.0 on InfoTrie's scale. They also gave media stories about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. What other stocks do shareholders of Merus Labs International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Merus Labs International investors own include Aurora Cannabis (ACB), Micron Technology (MU), Wheaton Precious Metals (WPM), Nexgen Energy (NXE), Canopy Growth (CGC), Aurora Cannabis (ACBFF), NeuLion (NLN), ProMetic Life Sciences (PLI), Dominion Diamond (DDC) and Royal Bank of Canada (RY). Who are Merus Labs International's key executives? Merus Labs International's management team includes the folowing people: Michael S. Cloutier, Independent Chairman of the BoardBarry Fishman, Chief Executive Officer, DirectorMichael Scott Bumby, Chief Financial OfficerRobert McLay, Vice President - Sales and MarketingFrank Rotmann, Vice President and Head of European OperationsRobert Bloch M.D., DirectorTheresa Sheila Firestone, Independent DirectorDavid D. Guebert CPA, Independent DirectorRobert S. Pollock, Independent DirectorTimothy G. Sorensen, Independent Director How do I buy shares of Merus Labs International? Shares of MSL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Merus Labs International's official website? The official website for Merus Labs International is http://www.meruslabs.com/. How can I contact Merus Labs International? Merus Labs International's mailing address is 100 Wellington St. West Suite 2110 Stn Toronto Dom PO Box 151, TORONTO, ON M5K 1H1, Canada. The specialty pharmaceutical company can be reached via phone at +1-905-7260995. MarketBeat Community Rating for Merus Labs International (TSE MSL)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 220 (Vote Outperform)Underperform Votes: 165 (Vote Underperform)Total Votes: 385MarketBeat's community ratings are surveys of what our community members think about Merus Labs International and other stocks. Vote "Outperform" if you believe MSL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/26/2019 by MarketBeat.com StaffFeatured Article: Why do companies engage in swaps?